-
- Posted Wednesday July 16, 2014
TGen cancer fundraising event moves to Scottsdale
9th annual 'stepNout' is planned Nov. 2 at Scottsdale Sports Complex
SCOTTSDALE, Ariz. - July 16, 2014 - The 9th
annual stepNout Run, Walk Dash, a major fundraising event
for pancreatic cancer research at the Translational Genomics Research
Institute (TGen), is moving to the Scottsdale Sports
Complex.
More than 1,000 participants have attended stepNout in
each of the past few years, and even more are expected to attend
this year's morning-long event on Nov. 2 in Scottsdale, featuring
fun, competitive races for all ages and abilities, including the
event's signature 5K run.
"We are thrilled to announce that our enormously successful
stepNout event will come to the City of Scottsdale. By
partnering in this new way with the City of Scottsdale, TGen is
generating answers and hope in the search for new treatments for
patients with pancreatic cancer," said TGen Foundation President
Michael Bassoff.
Vowing to "fight pancreatic cancer, one step at a time,"
stepNout organizers plan to raise more than $150,000 this
year on the way to eventually surpass the $1 million mark in
fundraising. Participants have donated more than $750,000 since the
event started in 2006 at Kiwanis Park in Tempe.
One of TGen's goals is to develop a method of early detection for
pancreatic cancer. Currently, there are no tests to catch this
disease in its early stages. As a result, it often is not diagnosed
until its late stages, making it more difficult to treat.
Pancreatic cancer this year will take the lives of nearly 40,000
Americans, the nation's fourth-leading cause of cancer-related
death.
TGen's pancreatic cancer research is led by Dr. Daniel D. Von
Hoff, TGen's Distinguished Professor and Physician-In-Chief, and
Chief Scientific Officer for the Virginia G. Piper Cancer Center
Clinical Trials at Scottsdale Healthcare, a partnership with
TGen.
Dr. Von Hoff is recognized as one of the world's leading
authorities on pancreatic cancer. He and his team have helped
develop three different treatment regimens to improve survival for
people with advanced pancreatic cancer. If applied earlier, these
regimens have the potential to make an even more powerful impact
against the disease.
"We are proud to add stepNout to the calendar of exciting
and meaningful events that call Scottsdale home. TGen is one of the
most significant contributors to Scottsdale's Cure Corridor of
research and medical facilities, offering world-class healthcare
opportunities to residents of Scottsdale and all Arizona citizens,"
said Scottsdale Mayor W.J. "Jim" Lane.
Scottsdale Sports Complex, 8081 E. Princess Drive, is a state-of
the-art, 71-acre competitive sport facility offering tournament
level playing conditions. The facility accommodates a variety of
flat field sports such as soccer, lacrosse, football, Ultimate
Frisbee and rugby. In addition to sports fields, the complex has a
lighted basketball court, a shaded playground, multi-use paths,
open park space and two restroom facilities.
*
If you go to stepNout
What: TGen's 9th annual stepNout
Run/Walk/Dash for pancreatic cancer research.
Where: Scottsdale
Sports Complex, 8081 E. Princess Drive, northeast of Hayden and
Bell roads, between Loop 101 and Frank Lloyd Wright
Boulevard.
When: 7-11 a.m. Sunday, Nov. 2.
Registration starts at 7 a.m.; races begin at 9 a.m.; an awards
ceremony is set for 10 a.m.; and a kids' dash is planned for 10:30
a.m.
Cost: Registration fees range from $15 to $35,
depending on age and competition. Children ages 4 and under are
free.
Registration: Register at the event, or register
online by Oct. 28 by visiting www.tgenfoundation.org/step.
Parking: Free.
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]